Rankings
▼
Calendar
RNA FY 2021 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
+37.4% YoY
Gross Profit
-$92M
-984.9% margin
Operating Income
-$118M
-1265.8% margin
Net Income
-$118M
-1265.4% margin
EPS (Diluted)
$-2.85
Cash Flow
Operating Cash Flow
-$95M
Free Cash Flow
-$99M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$428M
Total Liabilities
$46M
Stockholders' Equity
$381M
Cash & Equivalents
$320M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$7M
+37.4%
Gross Profit
-$92M
-$31M
-198.1%
Operating Income
-$118M
-$44M
-166.6%
Net Income
-$118M
-$44M
-166.1%
← Q4 2020
All Quarters
Q1 2021 →